Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control. [PDF]
Hsu MA +9 more
europepmc +1 more source
A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration. [PDF]
Wu B +5 more
europepmc +1 more source
The Immune Landscape of Chondrosarcoma: A Review of Tumor-Related Immune Cells. [PDF]
Silvaggio MT +5 more
europepmc +1 more source
Assessment of Programmed Cell Death Ligand-1 Expression in Oral Potentially Malignant Disorders and Tumor-Free Surgical Margins of Oral Squamous Cell Carcinoma: Protocol for a Retrospective Cross-Sectional Study. [PDF]
Sonone A +4 more
europepmc +1 more source
Ubiquitin-driven regulation of immune checkpoints in lung cancer: Mechanisms and therapeutic implications (Review). [PDF]
Chai L +6 more
europepmc +1 more source
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma. [PDF]
Cheng Z +7 more
europepmc +1 more source
Programmed death ligand-1 (PD-L1) expression in serous ovarian carcinoma with clinicopathological associations. [PDF]
Chaturvedi A +4 more
europepmc +1 more source
AAV8-Mediated Retinal PD-L1 Gene Transfer Attenuates Experimental Autoimmune Uveitis by Restoring Local Immune Tolerance. [PDF]
Lai Q +7 more
europepmc +1 more source
Conservation of Human IgSF Proteins Throughout Eukaryotic Evolution. [PDF]
Grudman S, Fiser A.
europepmc +1 more source
Immunoexpression of programmed death receptor 1 and its ligands in oral cavity squamous cell carcinoma. [PDF]
Anjos RS +5 more
europepmc +1 more source

